Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation
Author:
Affiliation:
1. David Geffen School of Medicine at UCLA; Los Angeles California
2. Division of Dermatology, Department of Medicine; David Geffen School of Medicine at UCLA; Los Angeles California
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dth.12559/fullpdf
Reference12 articles.
1. Ustekinumab as an alternative treatment option for chronic pityriasis rubra pilaris;Chowdhary;Case Reports in Dermatology,2015
2. Treatment options for pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center;Eastham;JAMA Dermatology,2014
3. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series;Garcovich;Journal of the European Academy of Dermatology and Venereology,2010
4. Pityriasis Rubra Pilaris;Griffiths;Clinical and Experimental Dermatology,1980
5. Pityriasis rubra pilaris: A review of diagnosis and treatment;Klein;American Journal of Clinical Dermatology,2010
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biologics for Treatment of Pityriasis Rubra Pilaris: A Literature Review;Journal of Cutaneous Medicine and Surgery;2024-03-28
2. Biologics for inherited disorders of keratinisation: A systematic review;Australasian Journal of Dermatology;2023-12-21
3. Targeting IL-1 controls refractory Pityriasis rubra pilaris;2023-10-13
4. Successful Treatment of Pityriasis Rubra Pilaris with Risankizumab in Children;Dermatology and Therapy;2023-09-13
5. Treatment Options for Juvenile Pityriasis Rubra Pilaris;Pediatric Drugs;2022-12-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3